Topic / France

wegovy comprimé.

Related reporting from CNBC, marketscreener.com, Clinical Trials Arena, Le Parisien, BFM, Le Télégramme: <a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPY19WVTI5bXJwOFVoVko4VUI3b3F3RWxTQnQ2MFZ1ZWpFUVJQWnR1UTBOZXhGTjFycE0tNFFscVhrWDdGSTg1SThpdEJXaDdESlh3OVhSeWNKdW5lSjk3Nkp6dmIzNUctTXdQeDFya1VGNnYtU29wVXpqbU5mdTl3SndIRnZHZ2hNTGVEX29DTExFMGt0OFUwWlNjQmjSAaIBQVVfeXFMTjM4TzVrZjhsd0lTczdLQU15UjNzNGFkRElnQjZyeXhOc3N5UHFPRDBVbG1DYUQ1NlN3ZFBsS2sySlI4US1zXzRPSDJ3SEtRSng0QVdqLXZIdUlETnpOVzhqRjN2aj <a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNU2ZoNmVBSE9YekpBYWdRMkVJSTlzcEcxdDlZc21JdHVVUE1ka2ZWeG0xWWx1T25vaDZxU1ZQR2dPeDNEUjNTNEZheWJ2UnpvZV9jZEVLb19MbVhmNnhmSUU4bVFCYlI1QWJU

RELATED REPORTS6publisher headlines
FIRST OBSERVED10/29/2026in public topic feeds
COUNTRYFranceregional coverage

News coverage

Latest headlines.

6 REPORTS
REPORT / 042026-10-16T07:00:00.000Z

CNBC

Eli Lilly's weight-loss pill wins EU drug regulator's backing

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPY19WVTI5bXJwOFVoVko4VUI3b3F3RWxTQnQ2MFZ1ZWpFUVJQWnR1UTBOZXhGTjFycE0tNFFscVhrWDdGSTg1SThpdEJXaDdESlh3OVhSeWNKdW5lSjk3Nkp6dmIzNUctTXdQeDFya1VGNnYtU29wVXpqbU5mdTl3SndIRnZHZ2hNTGVEX29DTExFMGt0OFUwWlNjQmjSAaIBQVVfeXFMTjM4TzVrZjhsd0lTczdLQU15UjNzNGFkRElnQjZyeXhOc3N5UHFPRDBVbG1DYUQ1NlN3ZFBsS2sySlI4US1zXzRPSDJ3SEtRSng0QVdqLXZIdUlETnpOVzhqRjN2aj

Read the original report More from CNBC about this topic
REPORT / 052026-09-01T07:00:00.000Z

marketscreener.com

Novo Nordisk launches Wegovy weight-loss pill in Germany

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNU2ZoNmVBSE9YekpBYWdRMkVJSTlzcEcxdDlZc21JdHVVUE1ka2ZWeG0xWWx1T25vaDZxU1ZQR2dPeDNEUjNTNEZheWJ2UnpvZV9jZEVLb19MbVhmNnhmSUU4bVFCYlI1QWJURTFLMTJKdjZ6VlRlWHZXSkktMlFZUGlCVFZnQTQyZksteXhtUVNYZVptdG1vaVg3Y3pFVmlqRU1zeHFBZ29NQ1hCNGc?oc=5" target="_blank">Novo Nordisk launches Wegovy weight-loss pill in Germany</a>&nbsp;&nbsp;<font color="#6f6f6f

Read the original report More from marketscreener.com about this topic
REPORT / 062025-12-19T08:00:00.000Z

Clinical Trials Arena

Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQSGgzMlV0TEdFRlV4MUFFa1RMbm5ETkE2VG1qVHcyUnRHM3MyYmlOR2IybGdfclM0eDdjNVRta0RZVlRnamNWcnFhTHFIZmlCcHYtOXNZdDE1REhydUZQZlNvTGtsYkJ1TlNDNXNyUUd5UndfQTBaejgyNThiTXB1aFRDN0ZVdnpSZDJ2Mnl3eW5hSW5aOFJydGZvOUVGTlZiUnZuU05XUGV5aVk?oc=5" target="_blank">Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs</a>&nbsp;&nbsp;<font color=

Read the original report More from Clinical Trials Arena about this topic